Merck Sharp & Dohme Corp. v. Albrecht (17-290)
Question
Is a state-law failure-to-warn claim preempted when the Food and Drug Administration (FDA) rejected the drug manufacturer’s proposal to warn about the risk after being provided with the relevant scientific data, or must such a case go to a jury for conjecture as to why the FDA rejected the proposed warning?Petitioner: Merck Sharp & Dohme Corp.
Respondent: Doris Albrecht, et al.
Granted: 2019-01-28 00:00:00
Decided: Pending
Argued: 2019-01-07 10:05:00
Uploaded: 2019-01-11 18:33:00
Advocates: Shay Dvoretzky, Malcolm L. Stewart, David C. Frederick
